SI1926472T1 - Stabilizirani in konzervirani ketotifenski oftalmični sestavki - Google Patents
Stabilizirani in konzervirani ketotifenski oftalmični sestavkiInfo
- Publication number
- SI1926472T1 SI1926472T1 SI200631024T SI200631024T SI1926472T1 SI 1926472 T1 SI1926472 T1 SI 1926472T1 SI 200631024 T SI200631024 T SI 200631024T SI 200631024 T SI200631024 T SI 200631024T SI 1926472 T1 SI1926472 T1 SI 1926472T1
- Authority
- SI
- Slovenia
- Prior art keywords
- ophthalmic compositions
- stabilized
- hydrogen peroxide
- preserved
- ketotifen ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/212,957 US20070048388A1 (en) | 2005-08-26 | 2005-08-26 | Stabilized and preserved ketotifen ophthalmic compositions |
PCT/US2006/033163 WO2007025094A2 (en) | 2005-08-26 | 2006-08-24 | Stabilized and preserved ketotifen ophthalmic compositions |
EP06802303A EP1926472B1 (en) | 2005-08-26 | 2006-08-24 | Stabilized and preserved ketotifen ophthalmic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1926472T1 true SI1926472T1 (sl) | 2011-07-29 |
Family
ID=37670685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200631024T SI1926472T1 (sl) | 2005-08-26 | 2006-08-24 | Stabilizirani in konzervirani ketotifenski oftalmični sestavki |
Country Status (19)
Country | Link |
---|---|
US (4) | US20070048388A1 (sl) |
EP (1) | EP1926472B1 (sl) |
JP (1) | JP5172678B2 (sl) |
KR (1) | KR20080042143A (sl) |
CN (1) | CN101252908B (sl) |
AT (1) | ATE505182T1 (sl) |
AU (2) | AU2006282980A1 (sl) |
BR (1) | BRPI0615384B8 (sl) |
CA (1) | CA2619834C (sl) |
CY (1) | CY1111678T1 (sl) |
DE (1) | DE602006021321D1 (sl) |
DK (1) | DK1926472T3 (sl) |
ES (1) | ES2363988T3 (sl) |
MX (1) | MX2008002653A (sl) |
PL (1) | PL1926472T3 (sl) |
PT (1) | PT1926472E (sl) |
RU (1) | RU2442583C2 (sl) |
SI (1) | SI1926472T1 (sl) |
WO (1) | WO2007025094A2 (sl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070208058A1 (en) * | 2004-10-25 | 2007-09-06 | Bryant Roy W | Stable Pharmaceutical Compositions and Methods of Making and Using Same |
US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
US20090220618A1 (en) * | 2008-02-29 | 2009-09-03 | Erning Xia | Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
WO2010107525A1 (en) * | 2009-03-17 | 2010-09-23 | Aciex Therapeutics, Inc. | Ophthalmic formulations of ketotifen and methods of use |
CN110024781A (zh) * | 2019-05-23 | 2019-07-19 | 昆明野水生物科技有限公司 | 一种在常温下能迅速杀灭芽孢的制剂及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614646A (en) * | 1984-12-24 | 1986-09-30 | The Dow Chemical Company | Stabilization of peroxide systems in the presence of alkaline earth metal ions |
US4819617A (en) * | 1986-09-04 | 1989-04-11 | University Of Florida | Viscoelastic material for ophthalmic surgery |
US5607698A (en) * | 1988-08-04 | 1997-03-04 | Ciba-Geigy Corporation | Method of preserving ophthalmic solution and compositions therefor |
DE68929516T2 (de) * | 1988-08-04 | 2005-01-05 | Novartis Ag | Verfahren zur Konservierung ophthalmischer Lösungen und Zusammensetzungen dafür |
US5019591A (en) * | 1989-02-17 | 1991-05-28 | Pennsylvania Research Corporation | Method for treating retinopathy and other small vessel disorders associated with diabetes |
EP0938896A1 (en) * | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
EP1119347B1 (en) * | 1998-10-08 | 2005-03-02 | Hampar L. Karagoezian | Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
ATE273033T1 (de) * | 2000-09-28 | 2004-08-15 | Novartis Pharma Gmbh | Stabilisierte ophthalmische wasserstoffperoxidlösung |
PE20030729A1 (es) * | 2002-01-18 | 2003-10-21 | Novartis Ag | Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas |
JP2004143157A (ja) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | 点眼剤 |
US20050244509A1 (en) * | 2004-03-17 | 2005-11-03 | Fu-Pao Tsao | Ophthalmic solutions |
-
2005
- 2005-08-26 US US11/212,957 patent/US20070048388A1/en not_active Abandoned
-
2006
- 2006-08-24 AT AT06802303T patent/ATE505182T1/de active
- 2006-08-24 DK DK06802303.5T patent/DK1926472T3/da active
- 2006-08-24 KR KR1020087007222A patent/KR20080042143A/ko not_active Application Discontinuation
- 2006-08-24 EP EP06802303A patent/EP1926472B1/en active Active
- 2006-08-24 RU RU2008111067/15A patent/RU2442583C2/ru not_active IP Right Cessation
- 2006-08-24 BR BRPI0615384A patent/BRPI0615384B8/pt active IP Right Grant
- 2006-08-24 CN CN200680031237XA patent/CN101252908B/zh not_active Expired - Fee Related
- 2006-08-24 SI SI200631024T patent/SI1926472T1/sl unknown
- 2006-08-24 ES ES06802303T patent/ES2363988T3/es active Active
- 2006-08-24 PT PT06802303T patent/PT1926472E/pt unknown
- 2006-08-24 MX MX2008002653A patent/MX2008002653A/es active IP Right Grant
- 2006-08-24 JP JP2008528166A patent/JP5172678B2/ja not_active Expired - Fee Related
- 2006-08-24 WO PCT/US2006/033163 patent/WO2007025094A2/en active Application Filing
- 2006-08-24 AU AU2006282980A patent/AU2006282980A1/en not_active Abandoned
- 2006-08-24 DE DE602006021321T patent/DE602006021321D1/de active Active
- 2006-08-24 PL PL06802303T patent/PL1926472T3/pl unknown
- 2006-08-24 CA CA2619834A patent/CA2619834C/en active Active
-
2008
- 2008-04-15 US US12/082,844 patent/US20080193558A1/en not_active Abandoned
-
2010
- 2010-11-03 AU AU2010241211A patent/AU2010241211B2/en not_active Ceased
-
2011
- 2011-06-28 CY CY20111100610T patent/CY1111678T1/el unknown
- 2011-12-20 US US13/330,992 patent/US20120095050A1/en not_active Abandoned
-
2012
- 2012-11-09 US US13/673,050 patent/US20130102634A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0615384A2 (pt) | 2011-05-17 |
AU2006282980A1 (en) | 2007-03-01 |
BRPI0615384B1 (pt) | 2019-06-18 |
BRPI0615384B8 (pt) | 2021-05-25 |
CN101252908A (zh) | 2008-08-27 |
WO2007025094A2 (en) | 2007-03-01 |
JP2009506065A (ja) | 2009-02-12 |
AU2010241211A1 (en) | 2010-11-25 |
RU2008111067A (ru) | 2009-10-10 |
US20120095050A1 (en) | 2012-04-19 |
RU2442583C2 (ru) | 2012-02-20 |
ES2363988T3 (es) | 2011-08-22 |
US20080193558A1 (en) | 2008-08-14 |
US20130102634A1 (en) | 2013-04-25 |
MX2008002653A (es) | 2008-03-18 |
PT1926472E (pt) | 2011-07-11 |
JP5172678B2 (ja) | 2013-03-27 |
KR20080042143A (ko) | 2008-05-14 |
DE602006021321D1 (de) | 2011-05-26 |
CN101252908B (zh) | 2011-09-14 |
WO2007025094A3 (en) | 2007-05-18 |
CY1111678T1 (el) | 2015-10-07 |
PL1926472T3 (pl) | 2011-09-30 |
EP1926472A2 (en) | 2008-06-04 |
CA2619834A1 (en) | 2007-03-01 |
EP1926472B1 (en) | 2011-04-13 |
US20070048388A1 (en) | 2007-03-01 |
DK1926472T3 (da) | 2011-07-18 |
ATE505182T1 (de) | 2011-04-15 |
CA2619834C (en) | 2014-05-06 |
AU2010241211B2 (en) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
MX2009005455A (es) | (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano. | |
RS20060320A (en) | Substituted indazole-o-glucosides | |
SG130189A1 (en) | Substituted indole-o-glucosides | |
MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
MX2009003821A (es) | Compuestos de n-aril pirazol para usarse contra la diabetes. | |
GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
UA87991C2 (en) | Substituted indole-o-glucosides | |
IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
EP1765335A4 (en) | PYRAZOLAMIDE DERIVATIVES, COMPOSITIONS AND METHODS OF APPLYING THESE COMPOUNDS | |
TW200740799A (en) | Alpha2C adrenoreceptor agonists | |
TW200604179A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
MXPA05012323A (es) | Sulfonamidas ciclicas para la inhibicion de gama-secretasa. | |
TW200714277A (en) | Methods and compositions for altering cell fuction | |
TW200745044A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
EA201170703A1 (ru) | Производные адамантилбензамида | |
MX2009005460A (es) | (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano. | |
MX2009003378A (es) | Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos. | |
TW200716088A (en) | Formulations and methods for treating amyloidosis | |
TNSN07240A1 (en) | Compounds for flaviviridae treatment | |
CY1111678T1 (el) | Σταθεροποιημενες και διατηρημενες οφθαλμικες ενωσεις κετοτιφενης | |
TW200720273A (en) | Pharmaceutically active spiro-benzimidazoles | |
EP2343048A3 (en) | Stabilized and preserved ketotifen ophthalmic compositions | |
HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
TW200815363A (en) | KV1.5 potassium channel inhibitors |